| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -9.61M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SLS returned +709.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +310.1% |
| 1 year | +709.4% |
| 5 years | +66.4% |
| 10 years | -99.9% |
| All-time high | $296,700.00 (May 2008) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SLS would be worth today ›No. SELLAS Life Sciences Group, Inc. has not paid a dividend in the past 12 months.
SELLAS Life Sciences Group, Inc. stock trades on NASDAQ under the ticker symbol SLS.
SELLAS Life Sciences Group, Inc. is part of the Healthcare sector.
SELLAS Life Sciences Group, Inc. has a market cap of 3.12B USD, based on the latest quote.
SELLAS Life Sciences Group, Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
